Arcellx

Biotechnology
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

$3.8B

Market Cap • 8/29/2025

2014

(11 years)

Founded

2022

(3 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country